Literature DB >> 22642189

Specificity of binding with matrix metalloproteinases.

Satya P Gupta1, Vaishali M Patil.   

Abstract

Matrix metalloproteinases (MMPs) regulate a wide range of biological functions; hence, they have invited great attention for the studies on their structures and functions, and since their overactivation leads to several diseases, the design and discovery of their potent inhibitors have become the need of the day. Since there have been so far discovered 28 different types of human MMPs, the specificity of binding of inhibitors with each different MMP needs special attention. The chapter presents the X-ray crystallographic and NMR studies on three-dimensional structures of a number of MMPs to reveal their catalytic site, subsites, specificity of binding with substrate and inhibitors, and catalytic mechanism. In addition to catalytic site, MMPs possess some subsites designated by unprimed and primed S, e.g., S1, S2, S3 and S1', S2', S3'. Among these, the S1' pocket varies the most among the different MMPs varying in both the amino acid makeup and depth of the pocket (shallow, intermediate, and deep pocket MMPs). This, along with the flexibility in the structures of MMPs, could be of great help in the design and the development of selective MMP inhibitors (MMPIs). The determination of affinity of inhibitors and the cleavage position of peptide substrates is mainly based on P1'-S1' interaction (P1', the group in inhibitor or substrate binding to S1' pocket of the enzyme), and it is the main determinant for the affinity of inhibitors and the cleavage position of peptide substrates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22642189     DOI: 10.1007/978-3-0348-0364-9_2

Source DB:  PubMed          Journal:  Exp Suppl        ISSN: 1664-431X


  13 in total

1.  An integrated structure- and pharmacophore-based MMP-12 virtual screening.

Authors:  Mohammad Ramezani; Jamal Shamsara
Journal:  Mol Divers       Date:  2018-02-08       Impact factor: 2.943

2.  Injectable and protease-degradable hydrogel for siRNA sequestration and triggered delivery to the heart.

Authors:  Leo L Wang; Jennifer J Chung; Elizabeth C Li; Selen Uman; Pavan Atluri; Jason A Burdick
Journal:  J Control Release       Date:  2018-07-04       Impact factor: 9.776

3.  The pore-forming toxin listeriolysin O is degraded by neutrophil metalloproteinase-8 and fails to mediate Listeria monocytogenes intracellular survival in neutrophils.

Authors:  Eusondia Arnett; Stephen Vadia; Colleen C Nackerman; Steve Oghumu; Abhay R Satoskar; Kenneth R McLeish; Silvia M Uriarte; Stephanie Seveau
Journal:  J Immunol       Date:  2013-12-06       Impact factor: 5.422

Review 4.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

Review 5.  Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis.

Authors:  Shun Li; David Mark Pritchard; Lu-Gang Yu
Journal:  Cancers (Basel)       Date:  2022-07-03       Impact factor: 6.575

6.  Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries.

Authors:  Dong Hyun Nam; Carlos Rodriguez; Albert G Remacle; Alex Y Strongin; Xin Ge
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-13       Impact factor: 11.205

7.  Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.

Authors:  Yonghao Jin; Mark D Roycik; Dale B Bosco; Qiang Cao; Manuel H Constantino; Martin A Schwartz; Qing-Xiang Amy Sang
Journal:  J Med Chem       Date:  2013-05-16       Impact factor: 7.446

8.  A Predictive HQSAR Model for a Series of Tricycle Core Containing MMP-12 Inhibitors with Dibenzofuran Ring.

Authors:  Jamal Shamsara; Ahmad Shahir-Sadr
Journal:  Int J Med Chem       Date:  2014-12-07

Review 9.  Matrix Metalloproteinases in Non-Neoplastic Disorders.

Authors:  Akinori Tokito; Michihisa Jougasaki
Journal:  Int J Mol Sci       Date:  2016-07-21       Impact factor: 5.923

Review 10.  Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).

Authors:  Loganathan Rangasamy; Bruno Di Geronimo; Irene Ortín; Claire Coderch; José María Zapico; Ana Ramos; Beatriz de Pascual-Teresa
Journal:  Molecules       Date:  2019-08-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.